Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 4
199
Views
5
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Bergamottin can be used to assess CYP3A-mediated intestinal first-pass metabolism without affecting P-glycoprotein-mediated efflux in rats

, , &
Pages 401-407 | Received 26 Mar 2019, Accepted 12 Jul 2019, Published online: 01 Aug 2019

References

  • Bailey DG, Spence JD, Munoz C, et al. (1991). Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268–9.
  • Cvetkovic M, Leake B, Fromm MF, et al. (1999). OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866–71.
  • de Castro WV, Mertens-Talcott S, Derendorf H, et al. (2008). Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. J Agric Food Chem 56:4840–5.
  • Ducharme MP, Warbasse LH, Edwards DJ. (1995). Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 57:485–91.
  • Fukuda K, Ohta T, Oshima Y, et al. (1997). Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 7:391–6.
  • He K, Iyer KR, Hayes RN, et al. (1998). Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 11:252–9.
  • Humphreys WG, Obermeier MT, Chong S, et al. (2003). Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazole. Xenobiotica 33:93–106.
  • Kamath AV, Yao M, Zhang Y, et al. (2005). Effect of fruit juices on the oral bioavailability of fexofenadine in rats. J Pharm Sci 94:233–9.
  • Kenny JR, Grime K. (2006). Pharmacokinetic consequences of time-dependent inhibition using the isolated perfused rat liver model. Xenobiotica 36:351–65.
  • Kupferschmidt HH, Fattinger KE, Ha HR, et al. (1998). Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 45:355–9.
  • Kupferschmidt HH, Ha HR, Ziegler WH, et al. (1995). Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 58:20–8.
  • Lilja JJ, Kivistö KT, Backman JT, et al. (1998). Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 64:655–60.
  • Matsuda Y, Konno Y, Hashimoto T, et al. (2015). Quantitative assessment of intestinal first-pass metabolism of oral drugs using portal-vein cannulated rats. Pharm Res 32:604–16.
  • Mohri K, Uesawa Y. (2001). Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm Res 18:177–82.
  • Paine MF, Hart HL, Ludington SS, et al. (2006). The human intestinal cytochrome P450 “pie”. Drug Metab Dispos 34:880–6.
  • Rioux N, Bellavance E, Bourg S, et al. (2013). Assessment of CYP3A-mediated drug-drug interaction potential for victim drugs using an in vivo rat model. Biopharm Drug Dispos 34:396–401.
  • Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–23.
  • Wang EJ, Casciano CN, Clement RP, et al. (2001). Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm Res 18:432–8.
  • Yamaoka K, Tanigawara Y, Nakagawa T, et al. (1981). A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879–85.
  • Zhang QY, Dunbar D, Ostrowska A, et al. (1999). Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos 27:804–9.
  • Zhang Y, Hsieh Y, Izumi T, et al. (1998). Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats. J Pharmacol Exp Ther 287:246–52.
  • Zuber R, Anzenbacherová E, Anzenbacher P. (2002). Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med 6:189–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.